PRSS3 and hepatocellular carcinoma: Furthermore, Lin et al. reported that PRSS3 was decreased in hepatocellular carcinoma (HCC) and PRSS3 overexpression inhibited HCC cell cycle, proliferation, migration, and invasion [18].